however, it did not affect hormonal profiles, inflammatory cytokines, or other oxidation biomarkers
Currently, there are approved medications, especially those that act as GLP-1 and/or GIP agonists, that achieve significant body weight reduction (more than 10%), compared to placebo
This recommendation exists because pregnant people (or those trying to become pregnant) were excluded from the initial clinical trialsa common practice in drug development for ethical reasonsleaving us without sufficient human safety data during pregnancy
Medical writing support was provided by Carsten Roepstorff, PhD, CR Pharma Consult, Copenhagen, Denmark, funded by Novo Nordisk
These medications can help lower blood pressure, improve blood sugar control, reduce cholesterol levels, and support overall cardiovascular health